Cell and Gene Therapy Market Size, Share, Opportunities and Scope from 2024 to 2030

A recent report published by Precision Business Insights on the cell and gene therapy market provides an in-depth analysis of segments and sub-segments in the global as well as regional.

The report " Cell and Gene Therapy Market  by Therapy Type (Cell Therapy (CAR-T Cell Therapy, Stem Cell Therapy, and Tumor Infiltrating Lymphocyte (TIL) Therapy), Gene Therapy (Gene Augmentation, Gene Editing, and Gene Slicing)), by Therapeutic Area (Oncology, Rare Disease, Neurological Disorders, Cardiovascular Diseases, and Others), by Delivery Method (In-Vivo, and Ex-Vivo), by End User (Hospitals and Specialty Clinics, Academic Research Institutions, and Biotechnology and Pharmaceutical Companies)- Global Forecasts to 2030"

The global cell and gene therapy market is projected to reach USD 23,189.2 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 20.4% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing consistent investment and consolidation.

Request sample report at
 https://www.precisionbusinessinsights.com/request-sample/?product_id=874004

Competitive Dashboard:
The prominent key players operating in the global cell and gene therapy market are Shire Plc, Novartis, Gilead Sciences, Amgen, Bayer, Orchard Therapeutics, Bristol-Myers Squibb, BioMarin, PTC Therapeutics, Bayer, Bristol-Myers Squibb, Biosyngen, CellVec, Agilent Technologies Inc., Wuxi advanced therapies

Regional Overview:
The report also examines the current concerns and their Future Effects on the Cell and Gene Therapy Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Cell and Gene Therapy Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

A Few Points from the Table of Contents –
1. Executive Summary
2. Global Cell and Gene Therapy Market Introduction
3. Global Cell and Gene Therapy Market Dynamics
4. Global Cell and Gene Therapy Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Cell and Gene Therapy Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Cell and Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Cell and Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Cell and Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Cell and Gene Therapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Cell and Gene Therapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations

Scope of The Report:

  • The cell and gene therapy market research report includes historical data, trending features, and market growth estimates for the future.
  • The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
  • The market report helps to provide the best results for business enhancement and business growth.
  • The report gives a comprehensive overview of both primary and secondary data.
  • The market key players covered here to help them strengthen their place in the market.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights
 | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747


manisha

395 Blog posts

Comments